texas oncology more breakthroughs. more victories
Some of our cancer centers are experiencing issues.  View More Important Notifications x

Share:

 
 

Vipal Pratin Durkal, M.D.

Vipal Pratin Durkal, M.D. Photo

Provider Type: Physician

Specialties:
Board Certifications:
  • Internal Medicine

Downloads

General Summary

Dr. Durkal has additional experience in clinical research, including novel imaging techniques used in cancer therapy.

Education

  • Fellowship in Hematology and Medical Oncology
    University of California Los Angeles Medical Center, Los Angeles, CA
  • Residency in Internal Medicine
    Medical College of Wisconsin, Milwaukee, WI
  • Medical Doctorate
    The University of Texas Health Science Center at Houston, Houston, TX

Medical Practice

  • Kelsey-Seybold Clinic, Staff, Hematology-Oncology, Houston, TX (August 2020)

Other Information

Dr. Durkal’s hobbies include running, cooking, community service and spending time with family. He is also interested in readings on health policy and medical history.

Publications

  • A Novel Artificial Intelligence Biomarker: Validation of the Automated Bone Scan Index (aBSI) in Veterans With Metastatic Prostate Cancer.

    Journal of Clinical Oncology, 2020

  • Exceptions to the Rule: Using Pathology as a Gold Standard To Evaluate the Sensitivity of PSMA PET/CT Modality

    ASCO, 2019

  • Can Response to Treatment Predict Outcome in Patients With Metastatic Pancreatic Adenocarcinoma (MPAC)?

    ASCO, 2016

  • Outcomes in Metastatic Pancreatic adenocarcinoma(MPAC) Patients Treated With FOLFIRINOX (FFX)/FOLFOX(FX) and Gemcitabine + Nab-Paclitaxel (NabG)

    ASCO, 2016

  • Can the Sequence of Chemotherapy Regimens Influence Outcome in Patients With Metastatic Pancreatic Adenocarcinoma (MPAC)?

    ASCO, 2016

Show all Publications
  • Location of Tumor in the Bladder Predicts Likelihood of Lymph Node Metasteses at Radical Cystectomy and Disease Recurrence

    The Journal of Urology, 2011